HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 1 filers reported holding HEMISPHERX BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 318 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 318 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 318 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 318 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 318 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 318 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 318 | +478.2% | 0.00% | – |
| Q2 2017 | $0 | – | 55 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 55 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Occidental Asset Management, LLC | 15,834 | $3,000 | 0.00% |
| VANGUARD GROUP INC | 444,640 | $80,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,080 | $0 | 0.00% |
| Waldron Private Wealth LLC | 11,000 | $1,000 | 0.00% |
| UBS Group AG | 51,343 | $9,000 | 0.00% |
| Paloma Partners Management Co | 50,019 | $9,000 | 0.00% |
| FMR LLC | 84 | $0 | 0.00% |
| Advisor Group, Inc. | 250 | $0 | 0.00% |
| Jacobi Capital Management LLC | 318 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 2,501 | $0 | 0.00% |